Tuccori, Marco

Pioglitazone use and risk of bladder cancer: Population based cohort study

Tuccori, M., Filion, K. B., Yin, H., Yu, O. H., Platt, R. W., & Azoulay, L. (2016) · BMJ

Metabolism, Diabetes, and CancerBladder and Urothelial Cancer Treatments

Cited by 237

Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems

Cutroneo, P. M., Sartori, D., Tuccori, M., Crisafulli, S., Battini, V., Carnovale, C., Rafaniello, C., Capuano, A., Poluzzi, E., Moretti, U., et al. (2024) · Frontiers in Drug Safety and Regulation

Pharmacovigilance and Adverse Drug ReactionsStatistical Methods in Clinical Trials

Cited by 224

Toxicities with immune checkpoint inhibitors: emerging priorities from disproportionality analysis of the FDA adverse event reporting system

Raschi, E., Mazzarella, A., Antonazzo, I. C., Bendinelli, N., Forcesi, E., Tuccori, M., Moretti, U., Poluzzi, E., & De Ponti, F. (2019) · Targeted Oncology

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 101

Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review

Tuccori, M., Testi, A., Antonioli, L., Fornai, M., Montagnani, S., Ghisu, N., Colucci, R., Corona, T., Blandizzi, C., & Tacca, M. D. (2009) · Clinical Therapeutics

Pregnancy and Medication ImpactMaternal Mental Health During Pregnancy and Postpartum

Cited by 95

The impact of the COVID-19 “Infodemic” on drug-utilization behaviors: implications for Pharmacovigilance

Tuccori, M., Convertino, I., Ferraro, S., Cappello, E., Valdiserra, G., Focosi, D., & Blandizzi, C. (2020) · Drug Safety

Misinformation and Its ImpactsPharmacovigilance and Adverse Drug Reactions

Cited by 80

Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome

Colucci, R., Gambaccini, D., Ghisu, N., Rossi, G., Costa, F., Tuccori, M., De Bortoli, N., Fornai, M., Antonioli, L., Ricchiuti, A., et al. (2013) · PLoS ONE

Gastrointestinal motility and disordersInfant Health and Development

Cited by 46

Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects

Convertino, I., Sansone, A. C., Marino, A., Galiulo, M. T., Mantarro, S., Antonioli, L., Fornai, M., Blandizzi, C., & Tuccori, M. (2016) · Drug Safety

Prenatal Substance Exposure EffectsPregnancy and Medication Impact

Cited by 32